Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT03121053
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT03121053
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Unknown status
Technical summary
Registry record NCT03121053. Randomized; no masking; primary purpose prevention. Start 2016-10 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement
- Acronym
- PANTER
- Condition
- Aortic Valve Disease
- Condition
- Chronic Kidney Disease
- Condition
- Contrast Induced Nephropathy
- Condition
- Acute Kidney Injury
- Intervention (Drug)
- sodium bicarbonate
- Intervention (Drug)
- hypotone saline
- Lead sponsor
- St. Antonius Hospital
Record details
- Record id
cardio:ct-nct03121053- Content hash
c432891d3c4fd9b40581fd44ac3330d059d3e0978a068e6f8681d61b5a30bfc5